Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry
Abstract: The Brazilian pharmaceutical industry is heavily dependent on external sources of inputs, capital, and technology. However, the emergence of technological opportunities and the development of biotechnology and the decline of the patent boom and resulting advances by generic drugs have open...
Main Authors: | Paulo Bastos Tigre, Caio Victor Machado França do Nascimento, Laís Silveira Costa |
---|---|
Format: | Article |
Language: | English |
Published: |
Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz
|
Series: | Cadernos de Saúde Pública |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2016001405009&lng=en&tlng=en |
Similar Items
-
Entry strategies into biosimilars: assessment of entry modes into the field of biosimilars from the perspective of pharmaceuticals, generics and biologics companies
by: Von Gehren, August Levin
Published: (2013) -
Análise econômica dos medicamentos genéricos no Brasil
by: Marislei Nishijima
Published: (2003) -
Análise econômica dos medicamentos genéricos no Brasil
by: Nishijima, Marislei
Published: (2003) -
Healthcare systems, the State, and innovation in the pharmaceutical industry
by: Ignacio José Godinho Delgado -
Os preços dos medicamentos de referência após a entrada dos medicamentos genéricos no mercado farmacêutico brasileiro
by: Marislei Nishijima
Published: (2008-06-01)